Products & Services · Inventory reserve
Tyvaso DPI — Inventory reserve
United Therapeutics Tyvaso DPI — Inventory reserve increased by 575.9% to $39.20M in Q1 2026 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementSegment
CategoryRisk
SignalLower is better
VolatilityStable
First reportedQ1 2025
Last reportedQ1 2026
How to read this metric
An increase in reserves suggests potential product expiration risks or declining demand, while a stable or decreasing reserve indicates healthy inventory turnover.
Detailed definition
Represents the valuation adjustment made to inventory for a specific product to account for potential obsolescence, expi...
Peer comparison
Standard inventory valuation adjustment reported by companies with physical product inventories.
Metric ID:
uthr_segment_tyvaso_dpi_inventory_reserveHistorical Data
2 periods
| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | $5.80M | $39.20M |
| QoQ Change | — | +575.9% |
| YoY Change | — | +575.9% |
Range$5.80M – $39.20M
Avg YoY Growth+575.9%
Median YoY Growth+575.9%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is United Therapeutics's tyvaso dpi — inventory reserve?
- United Therapeutics (UTHR) reported tyvaso dpi — inventory reserve of $39.20M in Q1 2026.
- What does tyvaso dpi — inventory reserve mean?
- The estimated value of inventory that may not be sold due to expiration or obsolescence.